TIDMINHC
RNS Number : 8770K
Induction Healthcare Group PLC
07 September 2021
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Directorate Changes
Senior management team optimises for growth and appointment of
Chief Technology Officer
Induction (AIM: INHC), a leading virtual care platform driving
digital transformation of healthcare systems worldwide, announces
important Group board and senior management team changes which the
Board believes will ideally position Induction for future growth
and success.
Dr Hugo Stephenson, Joint CEO, will move to a new role as Group
Executive Director, with a focus on group product strategy and
business development, particularly in the Asia Pacific region and
James Balmain, Joint CEO, will become Induction's sole CEO. Dr
Stephenson will also continue to manage the ongoing integration of
Induction Attend Anywhere following the acquisition and will play a
pivotal role in driving commercial and operational success.
The Board is also delighted to welcome Dave Williams as Chief
Technology Officer (CTO) with immediate effect. Dave joins from
Just Eat plc ("Just Eat"). He has over 25 years' experience leading
technology teams, including positions at CompuServe UK Ltd/ AOL UK
Ltd and the UK Hydrographic Office, a trading fund of the UK
Ministry of Defence. During his tenure as Chief Information Officer
at Just Eat, Dave held Group-wide accountability for the stability,
scalability and security of all e-commerce platforms and the
technology used by Just Eat employees globally.
James Balmain commented: "The acquisition of Attend Anywhere has
transformed Induction, increasing Group revenue as well as our
operational complexity, as our products underpin critical functions
within the NHS at scale. These changes will simplify our management
structure, increase accountability, and allow us to focus on both
delivery for our core UK customers and creation of new
opportunities outside the UK - particularly in the Asia-Pacific
region where many of our staff are now based.
"Dave is a fantastic addition to the Induction senior management
team. He has a strong track record with growth businesses and his
proven expertise as a technology leader will be invaluable to the
Group as we establish our integrated flexible care platform. I look
forward to working with him to enhance our portfolio of
solutions."
Hugo Stephenson commented: "The products we already deliver at
scale in the UK have significant potential in new markets.
Healthcare systems need tools that allow providers and patients to
work together more flexibly, freed from the constraints of having
everyone together in the same room at the same time. I am excited
about being able to personally focus on these international
opportunities while assisting James and the rest of the management
team as they continue to deliver operational and commercial success
from within our core business."
-ENDS-
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Dr Hugo Stephenson, Group Executive
Director
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0) 20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407
804 654
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) is a leading virtual care platform driving
digital transformation of healthcare systems worldwide. Induction
solutions enhance the investments hospitals have made and lay the
foundation for their future. Our products can enable information
sharing between busy doctors, alleviate operational burdens on
hospitals or put patients in better control of their care, all
while ensuring the highest standards of clinical safety and
information security. We unchain staff and patients from the
limitations of paper-based and desktop systems, creating
substantial time and cost efficiencies.
More than 225,000 hospital doctors across multiple territories,
including the UK, Ireland, Australia and South Africa, as well as a
rapidly growing number of more than 300,000 UK patients, choose
Induction solutions.
Induction Switch is the number one healthcare collaboration app
in the UK, used by the majority of hospital doctors within the NHS.
The app helps to increase productivity and enhance communication by
securely sharing phone numbers and bleeps, bookmarks, documents and
messages in a clinical setting.
Induction Guidance provides medical organisations, including
most hospital trusts within the NHS, with the ability to
collaboratively create, edit, and publish their own local medical
guidelines in a secure and locally administrated environment. This
increases knowledge of, and adherence to, guidance.
Induction Zesty is a market-leading digital platform for
patients visiting hospitals. The platform allows patients to book
and access their appointments, read their clinical letters, store a
copy of their clinical record and provide data to their care teams
remotely. It is not just a compelling patient experience, but also
delivers significant cost benefits to hospitals.
Induction Attend Anywhere is the UK market leader in secondary
care video consultations. It helps hospitals, health systems and
other customers offer video consultations to patients and service
users as a normal part of day-to-day clinical activity. Our vision
is for video consultations to improve lives and help address
social, access, equity and sustainability challenges by allowing
healthcare providers to determine how and when they see a patient
based on each individual case: in-person, via video or on the
telephone.
Induction HealthStream is a proprietary data integration
platform that reads and writes patient demographic, appointment and
clinical record data between a growing number of hospital EHR
systems and the Induction platforms. This connectivity between
stakeholders and legacy IT systems adds substantial value to
pre-existing health IT investment and allows large-scale adoption
of Induction app-based services.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAEADNKELLFEFA
(END) Dow Jones Newswires
September 07, 2021 02:00 ET (06:00 GMT)
Induction Healthcare (LSE:INHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Induction Healthcare (LSE:INHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
